Clinical Trial Update: Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the combination of alteplase (rt-PA) and Cerebrolysin in acute ischemic hemispheric stroke has completed. The sponsor is Eve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)
• Cerebrolysin

Snippet

Sponsor: Ever Neuro Pharma GmbH | Conditions: Stroke | Phase 3 | Status: COMPLETED